Longitudinal In Vivo Imaging and Quantification of Human Pancreatic Islet Grafting and Contributing Host Cells in the Anterior Eye Chamber
June 11th, 2020
5.1K views
The goal of this protocol is to continuously monitor the dynamics of the human pancreatic islet engraftment process and the contributing host versus donor cells. This is accomplished by transplanting human islets into the anterior chamber of the eye (ACE) of an NOD.(Cg)-Gt(ROSA)26Sortm4-Rag2-/-mouse recipient followed by repeated 2-photon imaging.
Overview
This protocol enables continuous monitoring of human pancreatic islet engraftment dynamics and the roles of host versus donor cells. By transplanting human islets into the anterior chamber of the eye (ACE) of NOD.(Cg)-Gt(ROSA)26Sor tm4 - Rag2 -/- mice, researchers can perform repeated 2-photon imaging to assess islet function and viability.
Key Study Components
Area of Science
- Neuroscience
- Transplantation Biology
- Imaging Techniques
Background
- The anterior chamber of the eye (ACE) is an optimal site for imaging.
- It allows long-term in vivo monitoring of islet cells.
- This method can be extended to study physiological and pathological conditions in real time.
- Noninvasive tracking of human pancreatic islets is possible with sub-cellular resolution.
Purpose of Study
- To evaluate the dynamics of islet grafting and survival.
- To improve understanding of beta cell replacement therapy.
- To assess the efficiency of islet grafting in vivo.
Methods Used
- Transplantation of human islets into the ACE of mice.
- Repeated 2-photon imaging for monitoring.
- Assessment of islet function and viability over time.
- Analysis of host versus donor cell contributions.
Main Results
- Successful long-term imaging of islet cells.
- Insights into the dynamics of islet engraftment.
- Evaluation of islet function and viability in a grafting situation.
- Improved understanding of challenges in islet grafting efficiency.
Conclusions
- The ACE technique provides a valuable tool for studying islet dynamics.
- It enhances the evaluation of beta cell replacement therapies.
- Further research can leverage this method for various physiological studies.
Frequently Asked Questions
What is the significance of using the ACE for imaging?
The ACE allows for noninvasive, long-term imaging of islet cells with sub-cellular resolution.
How does this study contribute to beta cell replacement therapy?
It provides insights into the dynamics of islet grafting and survival, which are crucial for improving therapy outcomes.
What imaging technique is used in this protocol?
The protocol utilizes repeated 2-photon imaging to monitor islet cells.
Can this method be applied to other types of cells?
Yes, the ACE technique can be extended to study various physiological and pathological conditions in real time.
What are the challenges in evaluating islet grafting?
Evaluating the efficiency of islet grafting and survival in vivo remains challenging despite improving success rates.
What type of mouse model is used in this study?
The study uses NOD.(Cg)-Gt(ROSA)26Sor tm4 - Rag2 -/- mouse recipients for islet transplantation.
Executive Industry Relevance
Longitudinal in vivo imaging of human pancreatic islet grafts in the anterior chamber of the eye enables continuous, noninvasive monitoring of graft survival, vascularization, and host cell contributions at sub-cellular resolution. This approach addresses a critical bottleneck in islet transplantation research by providing quantitative, real-time data on graft dynamics under physiological conditions. The method supports mechanistic de-risking of beta cell replacement therapies by clarifying the roles of donor versus recipient cells in graft encapsulation and revascularization, informing predictive confidence in preclinical development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by tracking human islet graft expansion and host cell contributions over time.
- Operational Value: Provides a disease-relevant system for functional target validation of pathways involved in graft survival and vascularization.
Screening & Assay Development
- Scientific Value: Generates quantitative dependent variable measurements such as islet volume, vascular density, and capsule formation for assay standardization.
- Operational Value: Supports reproducible, scalable imaging workflows for longitudinal screening of graft performance under varying conditions.
Translational & Preclinical Research
- Scientific Value: Offers a translational biomarker platform by correlating imaging readouts with graft viability and function.
- Operational Value: Facilitates preclinical model continuity from discovery through long-term engraftment studies.
Pipeline & Workflow Integration
The method integrates into the discovery continuum by enabling hypothesis testing in early discovery, supporting assay readiness in screening, and providing quantitative analytics for go/no-go decisions in preclinical advancement.
- Discovery Biology: Supports pathway clarification and biological de-risking by visualizing host-graft interactions in real time.
- Screening: Delivers assay standardization and quantitative outputs through automated segmentation of islet and vascular compartments.
- Analytics: Enables statistical analysis of longitudinal data to compare graft outcomes across experimental conditions.
- Translational Research: Connects imaging metrics to preclinical continuity by tracking vascularization and viability as translational biomarkers.
- Enterprise Reuse: Establishes a reusable imaging platform applicable to multiple tissue types beyond pancreatic islets, including diabetic complication models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in graft survival and host-mediated vascularization.
- Operational Value: Enhances reproducibility and scalability through standardized image acquisition and quantification protocols.
- Strategic Value: Improves go/no-go decisions by providing early, longitudinal readouts on graft functionality, reducing late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization of islet-based therapies based on quantifiable engraftment dynamics.
Implementation Considerations
- Requires expertise in microsurgical transplantation and two-photon microscopy.
- Dependent on specialized instrumentation including head holders, cannulas, and interactive image analysis software.
- Necessitates cross-team standardization for consistent image processing, particularly autofluorescence subtraction and channel segmentation.
- Involves adaptation considerations when extending the model to other tissues or pathological conditions.
- Limited by the need for immunocompromised recipient models to support human islet engraftment.
Biopharma FAQs
Why does null hypothesis testing matter for target validation in islet grafting studies?
Null hypothesis testing determines whether observed changes in graft volume or vascularization exceed background variability, ensuring that conclusions about host cell contributions are statistically robust and not due to random fluctuations in imaging data.
How does independent variable isolation fit the discovery pipeline for islet engraftment research?
Isolating variables such as recipient strain or islet preparation allows researchers to attribute changes in graft survival or revascularization to specific factors, supporting mechanistic de-risking and hypothesis-driven target validation in early discovery.
What quantitative dependent variable measurements enable assessment of islet graft success?
Quantitative measurements of islet volume, vascular density, and capsule-forming host cells provide objective endpoints to evaluate graft engraftment, viability, and functional integration over time, directly informing go/no-go decisions.
Why do replication requirements matter for cross-functional collaboration in longitudinal imaging studies?
Replication ensures that imaging protocols, segmentation methods, and quantitative outputs are consistent across operators and sites, enabling reliable data sharing between discovery, preclinical, and translational teams for unified decision-making.
What statistical analysis capabilities are required before implementing longitudinal islet graft imaging?
Implementation requires statistical tools to analyze longitudinal trends, compare group means, and assess significance of changes in graft metrics such as volume or vascularization, ensuring that observed effects are biologically meaningful and reproducible.
